Together we can make cancer care so much better
About Entia
At Entia, we are dedicated to transforming the cancer care experience through innovative, at-home blood monitoring solutions. Our mission is simple but powerful: to reduce the burden of cancer therapy on patients and healthcare systems, making treatment more tolerable and less disruptive to everyday life.
Our Vision
We envision a world where cancer care is personalised, proactive, and seamlessly integrated into everyday life. Our technology enables a future where treatment fits into life more naturally, minimising disruptions and maximising the effectiveness of care.
Our Promise
At Entia, we promise our partners, customers and users that we will deliver products that not only enhance the cancer treatment experience but free up patients to spend more time doing the things they love. We’re equally committed to helping healthcare systems deliver high-quality care that makes a real difference in patients' lives.
Meet the management team
Dr Toby Basey-Fisher, CEO
Tatiana Nianiaris, Head of Product
Ed Bean, COO
Dr Chris Burrows, CTO
Torsten Winther, Head of Manufacturing
Ewan Phillips, CFO
Meet the Board of Directors
Natalie Douglas
Chair
Dr Toby Basey-Fisher
CEO & Founder
Joanna Smart
Non-Exec, BGF
Neil Cameron
Non-Exec, Parkwalk
Richard Gourlay
Observer, SPV
Our journey so far
After years of co-development with thousands of cancer patients and healthcare professionals globally, we are now reshaping cancer therapy with Liberty
2015
2021
2016
Entia is founded by Dr Toby Basey-Fisher in response to seeing family members’ challenges through cancer therapy as well as through his collaborations with Imperial College NHS Healthcare Trust
Entia establishes collaborations with two of Europe's leading cancer centres to develop Liberty. Our work with their patients and healthcare professionals provides unparalleled insights to guide development.
We spend four years in various pilots, trials and development activities, including supporting a number of NHS centres throughout Covid with remote patient monitoring solutions.
2022
2023
We receive backing from leading European investment funds BGF and Parkwalk to support the final stages of development and rollout of Liberty.
The Liberty blood-count analyser is evaluated through four major trials involving 1,000s of patients and five NHS centres.
The Liberty full blood count analyser is approved for UK launch. In partnership with healthcare providers and leading life-science partners, we're able to finally bring Liberty to patients.
2024
Liberty makes front page news
Dr Toby Basey-Fisher and Entia are featured on the BBC to announce the deployment of Liberty into NHS trusts.